XOMA 240920 30.00P (XOMA240920P30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

XOMA240920P30000

Watchlist

3.00
-3.20-51.61%

15min DelayClose Aug 23 16:00 ET

3.00High3.00Low

Intraday

5D
Daily

News

Party Time: Brokers Just Made Major Increases To Their XOMA Royalty Corporation (NASDAQ:XOMA) Earnings Forecasts
Yahoo FinanceAug 18 08:05 ET
Express News | HC Wainwright & Co. Maintains Buy on XOMA Royalty, Raises Price Target to $117
BenzingaAug 15 06:22 ET
XOMA Royalty Analyst Ratings
BenzingaAug 15 06:19 ET · Ratings
H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Raises Target Price to $117
Moomoo NewsAug 14 06:31 ET · Ratings
Express News | XOMA Corp : H.c. Wainwright Raises Target Price to $117 From $74
ReutersAug 14 06:18 ET
Growth Investors: Industry Analysts Just Upgraded Their XOMA Royalty Corporation (NASDAQ:XOMA) Revenue Forecasts By 26%
Simply Wall StAug 14 06:09 ET

Comments

Trytosaveabit

Jun 12 06:34

Update

$XOMA Corp (XOMA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher

Meltyy

Mar 20 10:18

Biotech Stock News 3/20

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

Meltyy

Jan 12 09:27

Biotech Stock News 01/12 @ Open 🛎️📰
$Dyne Therapeutics (DYN.US)$ 4% Closing of public offering
$Geron (GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (ZEAL.US)$ 2% Capital increase
$XOMA Corp (XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences (CLRB.US)$ 1% Topline results @ conf. call
$CytomX (CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24

Moomoo AI

Jan 11 15:12

The FDA's acceptance of the NDA is a positive step for XOMA, triggering a milestone payment and bringing the drug closer to potential approval and commercialization. This could lead to future milestone and royalty payments for XOMA, depending on arimoclomol's commercial success.

Press Release: FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx

chgocal123

Jun 30, 2022 15:24

$XOMA Corp (XOMA.US)$ can't complain

XOMA Corp(XOMA) 22.280 +8.95%